Table 4 Clinical characteristics by gender
From: Safety of delivering bronchial thermoplasty in two treatment sessions
Females | Males | p | |
|---|---|---|---|
n | 28 | 25 | |
Age (years) | 55.2 ± 11.1 | 56.8 ± 15.4 | 0.670 |
BMI (kg/m2) | 31.5 ± 7.8 | 30.2 ± 6.5 | 0.516 |
ACQ | 3.5 ± 0.9 | 3.2 ± 1.1 | 0.255 |
FEV1 (%predicted) | 53.6 ± 19.4 | 48.4 ± 13.6 | 0.271 |
FEV1 (litre) | 1.29 ± 0.56 | 1.70 ± 0.65 | 0.017 |
Exacerbations (6 m) | 3 (4) | 2 (3.5) | 0.245 a |
Prednisolone (mg/d) | 10.2 ± 12.5 | 8.4 ± 13.2 | 0.603 |
Inhaled Steroids (eq/d) | 1675 ± 900 | 1796 ± 852 | 0.618 |
SABA (puffs/d) | 11.5 (13) | 6 (9) | 0.046 a |
Bl eosinophils (cells/μl) | 228 ± 246 | 262 ± 318 | 0.647 |
IgE (IU/ml) | 50 (179) | 52 (312) | 0.286a |
Total activations | 175 ± 36 | 183 ± 38 | 0.409 |